US Patent Issued to Amicus Therapeutics on Feb. 17 for "Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders" (Pennsylvania Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,736, issued on Feb. 17, was assigned to Amicus Therapeutics Inc. (Philadelphia).

"Compositions for preventing and/or treating degenerative disorders of the central nervous system and/or lysosomal storage disorders" was invented by Robert Boyd (Horsham, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides methods for treating lysosomal storage disorders such as Gaucher's disease, by using compounds of Formula III as described herein."

The patent was filed on June 13, 2022, under Application No. 17/838,817.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Par...